Stockreport

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins

Stevanato Group S.p.A. Ordinary Shares  (STVN) 
PDF - Establishes Fiscal 2026 Guidance - PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug d [Read more]